Summary
In the search for an improved prognosis in malignant melanoma after radical surgery, randomized trials are being conducted examining the results of immunostimulation (BCG or levamisole) with chemotherapy dimethyl — triazeno — imidazole — carboxamide (DTIC) in stage I melanoma. So far, no significant differences between the groups are evident. In stage III melanoma, a series of new agents are being rapidly screened and some appear promising. A closer look at the basic immunopathologic process during the growth of melanomas is might lead to a more effective control of this malignancy.
This work was made possible by the help of Deutsche Krebshilfe. The secretarial assistance of Ms. B. Kampmann is gratefully acknowledged
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Carter SK (1976) Dacarbazine. Int J Dermatol 15:59–63
Eilber FR, Morton DL, Holmes EC, Sparks FC, Ramming KP (1976) Adjuvant immunotherapy with BCG in treatment of regional lymph node metastases from malignant melanoma. N Engl J Med 294: 237–240
Frosch PF, Czarnetzki BM, Macher E, Grundmann E, Gottschalk I (1976) Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma. J Cancer Res Clin Oncol 95:281–286
Gutterman JU, McBride C, Freireich EJ, Mavligit G, Frei E, Hersh EM (1973) Active immunotheraply with BCG for recurrent malignant melanoma. Lancet 1:1208—1212
Henderson WR, Jong EC, Chi EY, Klebanoff SJ (1980) Mast cell-mediated tumor cell cytotoxicity: Role of peroxidase. Clin Res 28:416
Pinsky CM, Hirshaut Y, Wanebo HJ, Fortner J, Mike V, Schottenfeld D, Oettgen HF (1978) Surgical adjuvant immunotherapy with BCG in patients with malignant melanoma. Results of a prospective randomized trial. In: Terry WD, Windhurs D (eds) Immunotherapy of cancer: Present status of trials in man. Raven Press, New York, p 27
Robinson RW, Likar IN, Likar LJ (1978) Mast cells in normal, aged and diseased arteries. Monogr Atheroscler 89:73–116
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Czarnetzki, B.M., Macher, E., Behrendt, H., Lejeune, F. (1982). Current Status of Melanoma Chemotherapy and Immunotherapy. In: Mathé, G., Bonadonna, G., Salmon, S. (eds) Adjuvant Therapies of Cancer. Recent Results in Cancer Research, vol 80. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81685-7_42
Download citation
DOI: https://doi.org/10.1007/978-3-642-81685-7_42
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81687-1
Online ISBN: 978-3-642-81685-7
eBook Packages: Springer Book Archive